BURJEEL HOLDINGS PLC Management Discussion and Analysis Report for the Period Ended March 31,2026 | premargin
BURJEEL HOLDINGS PLC Management Discussion and Analysis Report for the Period Ended March 31,2026
·ADX·Financial Reports | Management Discussion and Analysis Report·May 6, 2026·View on exchange
AI Summary
Burjeel Holdings reported a 44.5% year-on-year increase in net profit to AED 57 million for Q1 2026, with revenue rising 5.1% to AED 1.3 billion (9.7% on a normalized basis) driven by a 7.2% growth in patient footfall to 1.8 million visits.
EBITDA increased 11.2% to AED 201 million, with the EBITDA margin expanding to 15.0% from 14.2% in Q1 2025, supported by procurement optimization and despite absorbing AED 11 million in ramp-up losses from new healthcare assets.
The Group’s Annual General Meeting approved a full-year dividend distribution of AED 120 million for FY2025; additionally, the company agreed to wind down its PhysioTherabia joint venture in Saudi Arabia, closing 28 centers.
Financial stability improved as net leverage reached 1.7x, compared to 1.8x at year-end 2025, while operating cash flow grew 13.1% to AED 161 million with a free cash flow conversion rate of 65%.